![Michael Hannay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 459 189 $ al 31/05/2026
Michael Hannay is currently Chief Product & Supply Chain Officer at Bicycle Therapeutics Plc since 2024 and holds the title of Professor at The College of Medicine.
Formerly, Mr. Hannay was Managing Director at Medical Technologies Innovation Facility from 2019 to 2022 and General Manager & Vice President at Thermo Fisher Scientific, Inc. from 2013 to 2016.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/01/2026 | 97.908 ( 0,26 % ) | 459 189 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 01/03/2024 |
The College of Medicine
 The College of Medicine Other Consumer ServicesConsumer Services Operates colleges | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Director Ejecutivo | 01/08/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
The College of Medicine
The College of Medicine Other Consumer ServicesConsumer Services Operates colleges | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
